{"type":"PR","pr":{"number":374,"head":"004155b3a0d5f65450a0538a67a01dba173e73ac"},"user":"silvia.vernotico","status":"pending_publish","branch":"cms/2019-08-22-hot-this-week-in-farmaceutica-younger-n-115","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.115","description":"La Food and Drug Administration statunitense ha approvato Xenleta (lefamulina), un antibiotico orale e endovenoso per il trattamento di adulti con polmonite batterica acquisita in comunit√† (CABP, community-acquired bacterial pneumonia).","objects":{"entry":{"path":"site/content/hotthisweek/2019-08-22-hot-this-week-in-farmaceutica-younger-n-115.md","sha":"76dc88cb94fe04a92461cd124ae9a7b0bf3c4b31"},"files":[]},"timeStamp":"2019-08-22T14:03:48.510Z"}